查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1532131

全球分子诊断市场评估：依产品和服务、依测试类型、依样本类型、依技术、依应用、依最终用户、依地区、机会、预测（2017-2031）

Molecular Diagnostics Market Assessment, By Product and Service, By Test Type, By Sample Type, By Technology, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 230 Pages | 商品交期: 3-5个工作天内

价格

全球分子诊断市场规模预计将从2023年的 143.1亿美元增至2031年的 308.3亿美元，预计在2024-2031年预测期内年复合成长率为 10.07%。

分子诊断提供重要讯息，帮助患者和医疗保健专业人员做出明智的治疗决策并改善结果。分子诊断技术已证明在临床实践中非常有用，因为它们可以提供灵敏且快速的检测方法，有助于监测各种传染病，包括癌症和其他慢性疾病。由于疾病、病原体数量的增加以及更容易感染疾病并需要持续诊断的人口老化，分子诊断市场预计将扩大。随着分子诊断的广泛使用，许多医学疾病已被有效识别，包括基因检测、微生物学、性传染病、肿瘤、血液筛检、病毒、组织学和产前诊断。以实验室为基础的分子诊断利用 DNA、RNA 和蛋白质的研究，是检测人类疾病的重要工具。分子诊断试剂盒和试剂根据其预期用途量身定制，并包含针对特定细菌、病毒或寄生虫序列的探针。由于生物标记特异性检测试剂盒的使用不断增加，分子诊断市场预计将扩大，这在开始任何药物或治疗之前都是不可或缺的。例如，美国 FDA 于2023年 5月批准了 Hologic, Inc. 的 Panther Fusion SARS-CoV-2/Flu A/B/RSV 检测的 510（k）许可。该检测使用分子诊断测试来区分四种最普遍的呼吸道病毒。

慢性病盛行率增加导致市场成长

由于慢性病盛行率不断上升，分子诊断市场显着扩大。人口老化、生活方式的改变和环境因素都会导致癌症、糖尿病和心血管疾病等慢性疾病的增加。需要先进的诊断方法来管理和有效治疗这些疾病。在这种情况下，使用先进技术来分析遗传、基因组和蛋白质组资料的分子诊断非常重要。识别与慢性病相关的特定生物标记和遗传变化有助于及时、准确地检测疾病。根据每位患者独特的分子特征客製化治疗方案可提高治疗效果并改善患者的治疗结果。例如，透过检测肿瘤特异性突变，分子诊断有可能透过最大限度地减少选择药物时的反覆试验来帮助确定最佳的癌症治疗方法。此类诊断可以更轻鬆地追踪疾病进展和身体对治疗的反应，可以快速改变治疗方法。

随着慢性病盛行率的持续成长，对分子诊断的需求日益成长，以提供全面、个人化的疾病病因和患者健康状况洞察。这些趋势推动分子诊断产业的持续发展和创新，有助于改善长期疾病治疗。例如，国际糖尿病联盟在2023年报告指出，全球 2 型糖尿病的盛行率显着增加。根据该联合会的研究，到2023年，全球将有5.37亿成年人患有糖尿病，比前一年大幅增加。人口老化、肥胖率上升和久坐的生活方式是造成这一趋势的原因。越来越多的第2 型糖尿病患者凸显出需要更好的预防措施和医疗方法来控制和减少这种长期疾病的影响。

科技发展推动市场成长

技术发展在扩大分子诊断市场方面发挥重要作用。高通量定序、即时 PCR 和新一代定序（NGS）技术的进步彻底改变了这一领域，提高了准确性、速度和全面的诊断能力。这些技术使得以以前难以想像的精度分析遗传物质成为可能，有助于疾病的早期检测和个人化治疗。

本报告研究和分析了全球分子诊断市场，提供市场规模和预测、市场动态以及主要参与者的现状和前景。

目录

第1章 专案范围与定义

第2章 研究方法

第3章 执行摘要

第4章 全球分子诊断市场展望（2017-2031）

  • 市场规模分析与预测
    • 金额
    • 数量
  • 市占率分析与预测
    • 依产品/服务
    • 按检定类型
    • 依样本类型
    • 依技术
    • 依用途
    • 依最终用户
    • 依地区
    • 市占率分析：依公司划分（金额）（前 5 名公司及其他 -2023年）
  • 市场地图分析（2023年）
    • 依产品/服务
    • 依检定类型
    • 依样本类型
    • 依技术
    • 依用途
    • 依最终用户
    • 依地区

第5章 北美分子诊断市场展望（2017-2031）

  • 市场规模分析与预测
    • 金额
    • 数量
  • 市占率分析与预测
    • 依产品/服务
    • 依检定类型
    • 依样本类型
    • 依技术
    • 依用途
    • 依最终用户
    • 占有率：依国家/地区
  • 市场评估：依国家分类
    • 美国分子诊断市场预测（2017-2031）
    • 加拿大
    • 墨西哥

第6章 欧洲分子诊断市场展望（2017-2031）

  • 德国
  • 法国
  • 义大利
  • 英国
  • 俄罗斯
  • 荷兰
  • 西班牙
  • 波兰

第7章 亚太分子诊断市场展望（2017-2031）

  • 印度
  • 中国
  • 日本
  • 澳洲
  • 越南
  • 韩国
  • 印尼
  • 菲律宾

第8章 南美洲分子诊断市场展望（2017-2031）

  • 巴西
  • 阿根廷

第9章 中东与非洲分子诊断市场前景（2017-2031）

  • 沙乌地阿拉伯
  • 阿拉伯联合大公国
  • 南非
  • 以色列

第10章 供需分析

第11章 进出口分析

第12章 价值链分析

第13章 波特五力分析

第14章 PESTLE分析

第15章 价格分析

第16章 市场动态

  • 市场驱动因素
  • 市场挑战

第17章 市场趋势与发展

第18章 监理架构与创新

  • 临床试验
  • 监理机关的核准

第19章 专利状况

第20章 个案研究

第21章 竞争态势

  • 前 5 名市场领导者的竞争矩阵
  • 前 5 名的公司的 SWOT 分析
  • 前10名主要企业状况
    • Danaher Corporation
    • F. Hoffmann-La Roche Ltd
    • Hologic, Inc.
    • Thermo Fisher Scientific Inc.
    • Abbott Laboratories
    • bioMerieux SA
    • Illumina, Inc.
    • QIAGEN N.V.
    • Myriad Genetics, Inc.
    • Siemens Healthineers

第22章 策略建议

第23章 关于本公司，免责声明

Product Code: MX11746

Global molecular diagnostics market is projected to witness a CAGR of 10.07% during the forecast period 2024-2031, growing from USD 14.31 billion in 2023 to USD 30.83 billion in 2031.

Molecular diagnostics help patients and healthcare professionals make educated decisions about their treatment, which leads to positive results, by offering vital information. Molecular diagnostics techniques have shown to be useful in clinical settings since they allow sensitive and quick detection methods, which makes it easier to monitor a variety of infectious disorders, including cancer and other chronic illnesses. The market for molecular diagnostics is expected to rise due to the growing illness, rising numbers of pathogens and even rising geriatric population, which is more prone to disease and hence needs continuous diagnosis. Numerous medical diseases have been effectively identified by the widespread use of molecular diagnostics, including genetic testing, microbiology, STDs, oncology, blood screening, virology, tissue type, and prenatal diagnosis. Using the study of DNA, RNA, or proteins, laboratory-based molecular diagnostics are vital instruments used for the detection of human diseases. Molecular diagnostic kits and reagents are tailored according to the desired use and contain probes that are unique to certain bacterial, viral, or parasitic sequences. The market for molecular diagnostics is expected to rise due to the growing use of biomarker-specific testing kits, which are essential before starting any kind of medication or treatment. The USFDA, for instance, granted 510(k) clearance for Hologic, Inc.'s Panther Fusion SARS-CoV-2/Flu A/B/RSV assay in May 2023. This assay distinguishes between the four most prevalent respiratory viruses by molecular diagnostic testing.

Market Growth Due to Rising Prevalence of Chronic Ailments

The market for molecular diagnostics is expanding significantly due to the increased incidence of chronic illnesses. Aging populations, changing lifestyles, and environmental factors are all contributing to the rise in chronic diseases such as cancer, diabetes, and cardiovascular ailments. For these illnesses to be managed and treated effectively, sophisticated diagnostic methods are required. In this setting, molecular diagnostics, which use advanced technology to analyze genetic, genomic, and proteomic data, are essential. Through the identification of particular biomarkers and genetic alterations linked to chronic disorders, they facilitate the timely and accurate detection of diseases. Customizing therapy regimens according to each patient's unique molecular profile increases treatment effectiveness and boosts patient outcomes. For instance, by detecting mutations unique to a tumor, molecular diagnostics might assist in determining the best cancer treatments by minimizing the need for trial-and-error when choosing medications. These diagnostics make it easier to continue tracking how the disease progresses and how the body responds to treatment, which enables prompt therapeutic modifications.

The need for molecular diagnostics that offer comprehensive and individualized insights into disease causes and patient health is growing as the prevalence of chronic diseases keeps rising. The pattern promotes ongoing development and innovation in the molecular diagnostics industry, aiding in the improved treatment of long-term medical disorders. For instance, the International Diabetes Federation reported in 2023 that there has been a notable global increase in prevalence of Type 2 diabetes. According to the federation's research, 537 million adults worldwide had diabetes in 2023, i.e., a significant increase over the previous year. Ageing populations, an increase in obesity rates, and sedentary lifestyles are blamed for the trend. The increasing number of people with Type 2 diabetes highlights the critical need for better preventative measures and medical therapies to control and lessen the effects of this long-term illness.

Technological Developments Fuel Market Growth

Technological developments have a major role in propelling the molecular diagnostics market's expansion. The area has seen a revolutionary change due to the advancement of high-throughput sequencing, real-time PCR, and next-generation sequencing (NGS) technologies, which offer enhanced precision, speed, and comprehensive diagnostic capabilities. These technologies make it possible to analyze genetic material with previously unheard-of precision, which helps with disease early detection and individualized therapy. High-throughput sequencing makes it possible to analyze multiple genetic variants which improves the efficiency of identifying mutations linked to disease. To diagnose infections and genetic abnormalities, real-time PCR improves the sensitivity and specificity of detecting particular genetic sequences. Deep genetic data insights are provided by NGS, which helps with focused therapy development and the identification of new biomarkers. Moreover, developments in data analytics and bioinformatics have enhanced the ability to comprehend intricate molecular data, enabling the extraction of useful insights from sizable datasets. Molecular diagnostics benefits from the integration of artificial intelligence (AI) and machine learning, which improves predictive analytics facilitates early diagnosis and personalized medication. The market for molecular diagnostics is growing due to these technical advancements since they provide more advanced instruments for accurate and effective illness detection and treatment. For instance, F. Hoffmann-La Roche Ltd. introduced the LightCycler PRO System in November 2023 to improve the usefulness of molecular PCR testing for applications such as in vitro diagnostics and translational research.

Instruments to Dominate the Global Molecular Diagnostics Market Share

Due to the high cost of equipment and the requirement for regular replacement or updates, the instruments category holds the highest revenue share of the market based on products and services. The rising incidence of chronic illnesses including cancer, genetic abnormalities, and infectious diseases, which need more sophisticated diagnostic techniques, expected to drive the demand for molecular diagnostic tools. This expansion can be linked to the growing need for personalized medicine and companion diagnostics, which need specifically designed instruments for particular uses. New and affordable diagnostic assays are anticipated to drive growth in the reagent and kit market. As more people are using electronic health record (EHR) and laboratory information management system (LIMS) systems, the software market is predicted to grow significantly over the course of the forecast period. More accurate and efficient patient diagnosis and treatment are expected to be made possible by the integration of molecular diagnostic software with electronic medical records.

Furthermore, it is anticipated that the advancement of machine learning and artificial intelligence (AI) technologies would support the growth of molecular diagnostic software by enabling the automated analysis of big datasets. For instance, Thermo Fisher Scientific, Inc. announced the release of a new digital PCR research tool called QuantStudio, Applied Biosystems, Absolute Q AutoRun dPCR (digital polymerase chain reaction) Suite in February 2023. Additionally, in May 2023, Sansure Biotech Inc. showcased its extensive line of IVD devices at EuroMedLab Rome 2023, which included the iconic III portable molecular workstations.

North America Dominates the Global Molecular Diagnostics Market Share

With the highest market share, North America led the largest proportion of the market. This is ascribed to the increasing prevalence of both infectious and chronic illnesses, which in turn motivates businesses to launch cutting-edge molecular diagnostic tests and propel market expansion. The growth is due to the robust healthcare infrastructure present in the region. Highly advanced diagnostic centers and laboratories in the region aid scientific development and growth, leading to a highly competitive market. For instance, QIAGEN N.V.'s therascreen PDGFRA RGQ PCR kit was approved by the USFDA in August 2023. This tool helps doctors detect individuals who have gastrointestinal stromal tumors (GIST). Additionally, the VIASURE Monkeypox viral Real-Time PCR Reagents, created by Becton, Dickinson and Company and CerTest Biotec, S.L. for Mpox viral identification, was authorized by the USFDA in January 2023. Furthermore, a strong healthcare system, excellent living standards, and consumer knowledge of early diagnosis serve as important growth-promoting factors.

Future Market Scenario (2024 - 2031F)

The main factors contributing to the anticipated growth of the molecular diagnostics market are the rising numbers of pathogens, the increasing prevalence of diseases, and, thus, the rising requirement to conduct diagnostic tests. However, the growing need to have precision medicine to maintain a healthy population is going to fuel market growth in the future. Players in this market are expanding at an unparalleled rate, introducing cost-effective and efficient technologies. Policies by welfare bodies and the government are greatly fueling the market expansion. For instance, the USFDA gave the COVID-19 and Flu Home Test, the first and only Emergency Use Authorization (EUA) for OTC usage at home and other non-laboratory locations.

Key Players Landscape and Outlook

Several companies are expanding their businesses by planning and adopting new strategies. They are complying with new strategic initiatives regarding the launch of newly developed molecular diagnostics to help researchers and strengthen their presence in the market. New product launches, agreements based on contracts, acquisitions and mergers, investments, and partnerships are a few ways through which they are trying to achieve the same.

For example, in October 2023, QIAGEN N.V. and Myriad Genetics, Inc. collaborated to create companion diagnostic tests for cancer based on PCR, dPCR, and NGS technology.

Additionally, Oxford Nanopore and bioMerieux SA established a strategic alliance in April 2023 to use nanopore technology to provide innovative cures for infectious diseases.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. Global Molecular Diagnostics Market Outlook, 2017-2031F

  • 4.1. Market Size Analysis & Forecast
    • 4.1.1. By Value
    • 4.1.2. By Volume
  • 4.2. Market Share Analysis & Forecast
    • 4.2.1. By Product and Service
      • 4.2.1.1. Reagents and Kits
      • 4.2.1.2. Instruments
      • 4.2.1.3. Services and Software
    • 4.2.2. By Test Type
      • 4.2.2.1. Lab Tests
      • 4.2.2.2. POC Tests
    • 4.2.3. By Sample Type
      • 4.2.3.1. Blood, Serum, and Plasma
      • 4.2.3.2. Urine
      • 4.2.3.3. Others
    • 4.2.4. By Technology
      • 4.2.4.1. Polymerase Chain Reaction (PCR)
      • 4.2.4.2. Isothermal Nucleic Acid Amplification Technology
      • 4.2.4.3. In-situ Hybridization
      • 4.2.4.4. DNA Sequencing
      • 4.2.4.5. Microarray
      • 4.2.4.6. Others
    • 4.2.5. By Application
      • 4.2.5.1. Infectious Diseases Tests
      • 4.2.5.2. Oncology Tests
      • 4.2.5.3. Genetic Tests
      • 4.2.5.4. Others
    • 4.2.6. By End-user
      • 4.2.6.1. Hospitals and Clinics
      • 4.2.6.2. Diagnostic Laboratories
      • 4.2.6.3. Others
    • 4.2.7. By Region
      • 4.2.7.1. North America
      • 4.2.7.2. Europe
      • 4.2.7.3. Asia-Pacific
      • 4.2.7.4. South America
      • 4.2.7.5. Middle East and Africa
    • 4.2.8. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2023)
  • 4.3. Market Map Analysis, 2023
    • 4.3.1. By Product and Service
    • 4.3.2. By Test Type
    • 4.3.3. By Sample Type
    • 4.3.4. By Technology
    • 4.3.5. By Application
    • 4.3.6. By End-user
    • 4.3.7. By Region

5. North America Molecular Diagnostics Market Outlook, 2017-2031F*

  • 5.1. Market Size Analysis & Forecast
    • 5.1.1. By Value
    • 5.1.2. By Volume
  • 5.2. Market Share Analysis & Forecast
    • 5.2.1. By Product and Service
      • 5.2.1.1. Reagents and Kits
      • 5.2.1.2. Instruments
      • 5.2.1.3. Services and Software
    • 5.2.2. By Test Type
      • 5.2.2.1. Lab Tests
      • 5.2.2.2. POC Tests
    • 5.2.3. By Sample Type
      • 5.2.3.1. Blood, Serum, and Plasma
      • 5.2.3.2. Urine
      • 5.2.3.3. Others
    • 5.2.4. By Technology
      • 5.2.4.1. Polymerase Chain Reaction (PCR)
      • 5.2.4.2. Isothermal Nucleic Acid Amplification Technology
      • 5.2.4.3. In-situ Hybridization
      • 5.2.4.4. DNA Sequencing
      • 5.2.4.5. Microarray
      • 5.2.4.6. Others
    • 5.2.5. By Application
      • 5.2.5.1. Infectious Diseases Tests
      • 5.2.5.2. Oncology Tests
      • 5.2.5.3. Genetic Tests
      • 5.2.5.4. Others
    • 5.2.6. By End-user
      • 5.2.6.1. Hospitals and Clinics
      • 5.2.6.2. Diagnostic Laboratories
      • 5.2.6.3. Others
    • 5.2.7. By Country Share
      • 5.2.7.1. United States
      • 5.2.7.2. Canada
      • 5.2.7.3. Mexico
  • 5.3. Country Market Assessment
    • 5.3.1. United States Molecular Diagnostics Market Outlook, 2017-2031F*
      • 5.3.1.1. Market Size Analysis & Forecast
        • 5.3.1.1.1. By Value
        • 5.3.1.1.2. By Volume
      • 5.3.1.2. Market Share Analysis & Forecast
        • 5.3.1.2.1. By Product and Service
          • 5.3.1.2.1.1. Reagents and Kits
          • 5.3.1.2.1.2. Instruments
          • 5.3.1.2.1.3. Services and Software
        • 5.3.1.2.2. By Test Type
          • 5.3.1.2.2.1. Lab Tests
          • 5.3.1.2.2.2. POC Tests
        • 5.3.1.2.3. By Sample Type
          • 5.3.1.2.3.1. Blood, Serum, and Plasma
          • 5.3.1.2.3.2. Urine
          • 5.3.1.2.3.3. Others
        • 5.3.1.2.4. By Technology
          • 5.3.1.2.4.1. Polymerase Chain Reaction (PCR)
          • 5.3.1.2.4.2. Isothermal Nucleic Acid Amplification Technology
          • 5.3.1.2.4.3. In-situ Hybridization
          • 5.3.1.2.4.4. DNA Sequencing
          • 5.3.1.2.4.5. Microarray
          • 5.3.1.2.4.6. Others
        • 5.3.1.2.5. By Application
          • 5.3.1.2.5.1. Infectious Diseases Tests
          • 5.3.1.2.5.2. Oncology Tests
          • 5.3.1.2.5.3. Genetic Tests
          • 5.3.1.2.5.4. Others
        • 5.3.1.2.6. By End-user
          • 5.3.1.2.6.1. Hospitals and Clinics
          • 5.3.1.2.6.2. Diagnostic Laboratories
          • 5.3.1.2.6.3. Others
    • 5.3.2. Canada
    • 5.3.3. Mexico

All segments will be provided for all regions and countries covered

6. Europe Molecular Diagnostics Market Outlook, 2017-2031F

  • 6.1. Germany
  • 6.2. France
  • 6.3. Italy
  • 6.4. United Kingdom
  • 6.5. Russia
  • 6.6. Netherlands
  • 6.7. Spain
  • 6.8. Poland

7. Asia-Pacific Molecular Diagnostics Market Outlook, 2017-2031F

  • 7.1. India
  • 7.2. China
  • 7.3. Japan
  • 7.4. Australia
  • 7.5. Vietnam
  • 7.6. South Korea
  • 7.7. Indonesia
  • 7.8. Philippines

8. South America Molecular Diagnostics Market Outlook, 2017-2031F

  • 8.1. Brazil
  • 8.2. Argentina

9. Middle East and Africa Molecular Diagnostics Market Outlook, 2017-2031F

  • 9.1. Saudi Arabia
  • 9.2. UAE
  • 9.3. South Africa
  • 9.4. Israel

10. Demand Supply Analysis

11. Import and Export Analysis

12. Value Chain Analysis

13. Porter's Five Forces Analysis

14. PESTLE Analysis

15. Pricing Analysis

16. Market Dynamics

  • 16.1. Market Drivers
  • 16.2. Market Challenges

17. Market Trends and Developments

18. Regulatory Framework and Innovation

  • 18.1. Clinical Trials
  • 18.2. Regulatory Approvals

19. Patent Landscape

20. Case Studies

21. Competitive Landscape

  • 21.1. Competition Matrix of Top 5 Market Leaders
  • 21.2. SWOT Analysis for Top 5 Players
  • 21.3. Key Players Landscape for Top 10 Market Players
    • 21.3.1. Danaher Corporation
      • 21.3.1.1. Company Details
      • 21.3.1.2. Key Management Personnel
      • 21.3.1.3. Products and Services
      • 21.3.1.4. Financials (As Reported)
      • 21.3.1.5. Key Market Focus and Geographical Presence
      • 21.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisition
    • 21.3.2. F. Hoffmann-La Roche Ltd
    • 21.3.3. Hologic, Inc.
    • 21.3.4. Thermo Fisher Scientific Inc.
    • 21.3.5. Abbott Laboratories
    • 21.3.6. bioMerieux SA
    • 21.3.7. Illumina, Inc.
    • 21.3.8. QIAGEN N.V.
    • 21.3.9. Myriad Genetics, Inc.
    • 21.3.10. Siemens Healthineers

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

22. Strategic Recommendations

23. About Us and Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global Molecular Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 2. Global Molecular Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 3. Global Molecular Diagnostics Market Share (%), By Product and Service, 2017-2031F
  • Figure 4. Global Molecular Diagnostics Market Share (%), By Test Type, 2017-2031F
  • Figure 5. Global Molecular Diagnostics Market Share (%), By Sample Type, 2017-2031F
  • Figure 6. Global Molecular Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 7. Global Molecular Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 8. Global Molecular Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 9. Global Molecular Diagnostics Market Share (%), By Region, 2017-2031F
  • Figure 10. North America Molecular Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 11. North America Molecular Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 12. North America Molecular Diagnostics Market Share (%), By Product and Service, 2017-2031F
  • Figure 13. North America Molecular Diagnostics Market Share (%), By Test Type, 2017-2031F
  • Figure 14. North America Molecular Diagnostics Market Share (%), By Sample Type, 2017-2031F
  • Figure 15. North America Molecular Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 16. North America Molecular Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 17. North America Molecular Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 18. North America Molecular Diagnostics Market Share (%), By Country, 2017-2031F
  • Figure 19. United States Molecular Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 20. United States Molecular Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 21. United States Molecular Diagnostics Market Share (%), By Product and Service, 2017-2031F
  • Figure 22. United States Molecular Diagnostics Market Share (%), By Test Type, 2017-2031F
  • Figure 23. United States Molecular Diagnostics Market Share (%), By Sample Type, 2017-2031F
  • Figure 24. United States Molecular Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 25. United States Molecular Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 26. United States Molecular Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 27. Canada Molecular Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 28. Canada Molecular Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 29. Canada Molecular Diagnostics Market Share (%), By Product and Service, 2017-2031F
  • Figure 30. Canada Molecular Diagnostics Market Share (%), By Test Type, 2017-2031F
  • Figure 31. Canada Molecular Diagnostics Market Share (%), By Sample Type, 2017-2031F
  • Figure 32. Canada Molecular Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 33. Canada Molecular Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 34. Canada Molecular Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 35. Mexico Molecular Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 36. Mexico Molecular Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 37. Mexico Molecular Diagnostics Market Share (%), By Product and Service, 2017-2031F
  • Figure 38. Mexico Molecular Diagnostics Market Share (%), By Test Type, 2017-2031F
  • Figure 39. Mexico Molecular Diagnostics Market Share (%), By Sample Type, 2017-2031F
  • Figure 40. Mexico Molecular Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 41. Mexico Molecular Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 42. Mexico Molecular Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 43. Europe Molecular Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 44. Europe Molecular Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 45. Europe Molecular Diagnostics Market Share (%), By Product and Service, 2017-2031F
  • Figure 46. Europe Molecular Diagnostics Market Share (%), By Test Type, 2017-2031F
  • Figure 47. Europe Molecular Diagnostics Market Share (%), By Sample Type, 2017-2031F
  • Figure 48. Europe Molecular Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 49. Europe Molecular Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 50. Europe Molecular Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 51. Europe Molecular Diagnostics Market Share (%), By Country, 2017-2031F
  • Figure 52. Germany Molecular Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 53. Germany Molecular Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 54. Germany Molecular Diagnostics Market Share (%), By Product and Service, 2017-2031F
  • Figure 55. Germany Molecular Diagnostics Market Share (%), By Test Type, 2017-2031F
  • Figure 56. Germany Molecular Diagnostics Market Share (%), By Sample Type, 2017-2031F
  • Figure 57. Germany Molecular Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 58. Germany Molecular Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 59. Germany Molecular Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 60. France Molecular Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 61. France Molecular Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 62. France Molecular Diagnostics Market Share (%), By Product and Service, 2017-2031F
  • Figure 63. France Molecular Diagnostics Market Share (%), By Test Type, 2017-2031F
  • Figure 64. France Molecular Diagnostics Market Share (%), By Sample Type, 2017-2031F
  • Figure 65. France Molecular Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 66. France Molecular Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 67. France Molecular Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 68. Italy Molecular Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 69. Italy Molecular Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 70. Italy Molecular Diagnostics Market Share (%), By Product and Service, 2017-2031F
  • Figure 71. Italy Molecular Diagnostics Market Share (%), By Test Type, 2017-2031F
  • Figure 72. Italy Molecular Diagnostics Market Share (%), By Sample Type, 2017-2031F
  • Figure 73. Italy Molecular Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 74. Italy Molecular Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 75. Italy Molecular Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 76. United Kingdom Molecular Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 77. United Kingdom Molecular Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 78. United Kingdom Molecular Diagnostics Market Share (%), By Product and Service, 2017-2031F
  • Figure 79. United Kingdom Molecular Diagnostics Market Share (%), By Test Type, 2017-2031F
  • Figure 80. United Kingdom Molecular Diagnostics Market Share (%), By Sample Type, 2017-2031F
  • Figure 81. United Kingdom Molecular Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 82. United Kingdom Molecular Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 83. United Kingdom Molecular Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 84. Russia Molecular Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 85. Russia Molecular Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 86. Russia Molecular Diagnostics Market Share (%), By Product and Service, 2017-2031F
  • Figure 87. Russia Molecular Diagnostics Market Share (%), By Test Type, 2017-2031F
  • Figure 88. Russia Molecular Diagnostics Market Share (%), By Sample Type, 2017-2031F
  • Figure 89. Russia Molecular Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 90. Russia Molecular Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 91.
  • Figure 92. Russia Molecular Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 93. Netherlands Molecular Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 94. Netherlands Molecular Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 95. Netherlands Molecular Diagnostics Market Share (%), By Product and Service, 2017-2031F
  • Figure 96. Netherlands Molecular Diagnostics Market Share (%), By Test Type, 2017-2031F
  • Figure 97. Netherlands Molecular Diagnostics Market Share (%), By Sample Type, 2017-2031F
  • Figure 98. Netherlands Molecular Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 99. Netherlands Molecular Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 100. Netherlands Molecular Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 101. Spain Molecular Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 102. Spain Molecular Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 103. Spain Molecular Diagnostics Market Share (%), By Product and Service, 2017-2031F
  • Figure 104. Spain Molecular Diagnostics Market Share (%), By Test Type, 2017-2031F
  • Figure 105. Spain Molecular Diagnostics Market Share (%), By Sample Type, 2017-2031F
  • Figure 106. Spain Molecular Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 107. Spain Molecular Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 108. Spain Molecular Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 109. Turkey Molecular Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 110. Turkey Molecular Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 111. Turkey Molecular Diagnostics Market Share (%), By Product and Service, 2017-2031F
  • Figure 112. Turkey Molecular Diagnostics Market Share (%), By Test Type, 2017-2031F
  • Figure 113. Turkey Molecular Diagnostics Market Share (%), By Sample Type, 2017-2031F
  • Figure 114. Turkey Molecular Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 115. Turkey Molecular Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 116. Turkey Molecular Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 117. Poland Molecular Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 118. Poland Molecular Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 119. Poland Molecular Diagnostics Market Share (%), By Product and Service, 2017-2031F
  • Figure 120. Poland Molecular Diagnostics Market Share (%), By Test Type, 2017-2031F
  • Figure 121. Poland Molecular Diagnostics Market Share (%), By Sample Type, 2017-2031F
  • Figure 122. Poland Molecular Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 123. Poland Molecular Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 124. Poland Molecular Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 125. South America Molecular Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 126. South America Molecular Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 127. South America Molecular Diagnostics Market Share (%), By Product and Service, 2017-2031F
  • Figure 128. South America Molecular Diagnostics Market Share (%), By Test Type, 2017-2031F
  • Figure 129. South America Molecular Diagnostics Market Share (%), By Sample Type, 2017-2031F
  • Figure 130. South America Molecular Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 131. South America Molecular Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 132. South America Molecular Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 133. South America Molecular Diagnostics Market Share (%), By Country, 2017-2031F
  • Figure 134. Brazil Molecular Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 135. Brazil Molecular Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 136. Brazil Molecular Diagnostics Market Share (%), By Product and Service, 2017-2031F
  • Figure 137. Brazil Molecular Diagnostics Market Share (%), By Test Type, 2017-2031F
  • Figure 138. Brazil Molecular Diagnostics Market Share (%), By Sample Type, 2017-2031F
  • Figure 139. Brazil Molecular Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 140. Brazil Molecular Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 141. Brazil Molecular Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 142. Argentina Molecular Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 143. Argentina Molecular Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 144. Argentina Molecular Diagnostics Market Share (%), By Product and Service, 2017-2031F
  • Figure 145. Argentina Molecular Diagnostics Market Share (%), By Test Type, 2017-2031F
  • Figure 146. Argentina Molecular Diagnostics Market Share (%), By Sample Type, 2017-2031F
  • Figure 147. Argentina Molecular Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 148. Argentina Molecular Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 149. Argentina Molecular Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 150. Asia-Pacific Molecular Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 151. Asia-Pacific Molecular Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 152. Asia-Pacific Molecular Diagnostics Market Share (%), By Product and Service, 2017-2031F
  • Figure 153. Asia-Pacific Molecular Diagnostics Market Share (%), By Test Type, 2017-2031F
  • Figure 154. Asia-Pacific Molecular Diagnostics Market Share (%), By Sample Type, 2017-2031F
  • Figure 155. Asia-Pacific Molecular Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 156. Asia-Pacific Molecular Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 157. Asia-Pacific Molecular Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 158. Asia-Pacific Molecular Diagnostics Market Share (%), By Country, 2017-2031F
  • Figure 159. India Molecular Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 160. India Molecular Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 161. India Molecular Diagnostics Market Share (%), By Product and Service, 2017-2031F
  • Figure 162. India Molecular Diagnostics Market Share (%), By Test Type, 2017-2031F
  • Figure 163. India Molecular Diagnostics Market Share (%), By Sample Type, 2017-2031F
  • Figure 164. India Molecular Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 165. India Molecular Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 166. India Molecular Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 167. China Molecular Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 168. China Molecular Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 169. China Molecular Diagnostics Market Share (%), By Product and Service, 2017-2031F
  • Figure 170. China Molecular Diagnostics Market Share (%), By Test Type, 2017-2031F
  • Figure 171. China Molecular Diagnostics Market Share (%), By Sample Type, 2017-2031F
  • Figure 172. China Molecular Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 173. China Molecular Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 174. China Molecular Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 175. Japan Molecular Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 176. Japan Molecular Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 177. Japan Molecular Diagnostics Market Share (%), By Product and Service, 2017-2031F
  • Figure 178. Japan Molecular Diagnostics Market Share (%), By Test Type, 2017-2031F
  • Figure 179. Japan Molecular Diagnostics Market Share (%), By Sample Type, 2017-2031F
  • Figure 180. Japan Molecular Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 181. Japan Molecular Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 182. Japan Molecular Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 183. Australia Molecular Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 184. Australia Molecular Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 185. Australia Molecular Diagnostics Market Share (%), By Product and Service, 2017-2031F
  • Figure 186. Australia Molecular Diagnostics Market Share (%), By Test Type, 2017-2031F
  • Figure 187. Australia Molecular Diagnostics Market Share (%), By Sample Type, 2017-2031F
  • Figure 188. Australia Molecular Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 189. Australia Molecular Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 190. Australia Molecular Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 191. Vietnam Molecular Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 192. Vietnam Molecular Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 193. Vietnam Molecular Diagnostics Market Share (%), By Product and Service, 2017-2031F
  • Figure 194. Vietnam Molecular Diagnostics Market Share (%), By Test Type, 2017-2031F
  • Figure 195. Vietnam Molecular Diagnostics Market Share (%), By Sample Type, 2017-2031F
  • Figure 196. Vietnam Molecular Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 197. Vietnam Molecular Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 198. Vietnam Molecular Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 199. South Korea Molecular Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 200. South Korea Molecular Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 201. South Korea Molecular Diagnostics Market Share (%), By Product and Service, 2017-2031F
  • Figure 202. South Korea Molecular Diagnostics Market Share (%), By Test Type, 2017-2031F
  • Figure 203. South Korea Molecular Diagnostics Market Share (%), By Sample Type, 2017-2031F
  • Figure 204. South Korea Molecular Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 205. South Korea Molecular Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 206. South Korea Molecular Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 207. Indonesia Molecular Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 208. Indonesia Molecular Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 209. Indonesia Molecular Diagnostics Market Share (%), By Product and Service, 2017-2031F
  • Figure 210. Indonesia Molecular Diagnostics Market Share (%), By Test Type, 2017-2031F
  • Figure 211. Indonesia Molecular Diagnostics Market Share (%), By Sample Type, 2017-2031F
  • Figure 212. Indonesia Molecular Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 213. Indonesia Molecular Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 214. Indonesia Molecular Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 215. Philippines Molecular Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 216. Philippines Molecular Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 217. Philippines Molecular Diagnostics Market Share (%), By Product and Service, 2017-2031F
  • Figure 218. Philippines Molecular Diagnostics Market Share (%), By Test Type, 2017-2031F
  • Figure 219. Philippines Molecular Diagnostics Market Share (%), By Sample Type, 2017-2031F
  • Figure 220. Philippines Molecular Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 221. Philippines Molecular Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 222. Philippines Molecular Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 223. Middle East & Africa Molecular Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 224. Middle East & Africa Molecular Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 225. Middle East & Africa Molecular Diagnostics Market Share (%), By Product and Service, 2017-2031F
  • Figure 226. Middle East & Africa Molecular Diagnostics Market Share (%), By Test Type, 2017-2031F
  • Figure 227. Middle East & Africa Molecular Diagnostics Market Share (%), By Sample Type, 2017-2031F
  • Figure 228. Middle East & Africa Molecular Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 229. Middle East & Africa Molecular Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 230. Middle East & Africa Molecular Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 231. Middle East & Africa Molecular Diagnostics Market Share (%), By Country, 2017-2031F
  • Figure 232. Saudi Arabia Molecular Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 233. Saudi Arabia Molecular Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 234. Saudi Arabia Molecular Diagnostics Market Share (%), By Product and Service, 2017-2031F
  • Figure 235. Saudi Arabia Molecular Diagnostics Market Share (%), By Test Type, 2017-2031F
  • Figure 236. Saudi Arabia Molecular Diagnostics Market Share (%), By Sample Type, 2017-2031F
  • Figure 237. Saudi Arabia Molecular Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 238. Saudi Arabia Molecular Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 239. Saudi Arabia Molecular Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 240. UAE Molecular Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 241. UAE Molecular Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 242. UAE Molecular Diagnostics Market Share (%), By Product and Service, 2017-2031F
  • Figure 243. UAE Molecular Diagnostics Market Share (%), By Test Type, 2017-2031F
  • Figure 244. UAE Molecular Diagnostics Market Share (%), By Sample Type, 2017-2031F
  • Figure 245. UAE Molecular Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 246. UAE Molecular Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 247. UAE Molecular Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 248. South Africa Molecular Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 249. South Africa Molecular Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 250. South Africa Molecular Diagnostics Market Share (%), By Product and Service, 2017-2031F
  • Figure 251. South Africa Molecular Diagnostics Market Share (%), By Test Type, 2017-2031F
  • Figure 252. South Africa Molecular Diagnostics Market Share (%), By Sample Type, 2017-2031F
  • Figure 253. South Africa Molecular Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 254. South Africa Molecular Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 255. South Africa Molecular Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 256. By Product and Service Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 257. By Test Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 258. By Sample Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 259. By Technology Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 260. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 261. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 262. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023